318 related articles for article (PubMed ID: 8299567)
1. Effects of differentiation on neuropeptide-Y receptors and responses in rat pheochromocytoma cells.
DiMaggio DA; Farah JM; Westfall TC
Endocrinology; 1994 Feb; 134(2):719-27. PubMed ID: 8299567
[TBL] [Abstract][Full Text] [Related]
2. Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype.
Raposinho PD; Broqua P; Pierroz DD; Hayward A; Dumont Y; Quirion R; Junien JL; Aubert ML
Endocrinology; 1999 Sep; 140(9):4046-55. PubMed ID: 10465275
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptide-Y and Y-receptors in the autocrine-paracrine regulation of adrenal gland under physiological and pathophysiological conditions (Review).
Spinazzi R; Andreis PG; Nussdorfer GG
Int J Mol Med; 2005 Jan; 15(1):3-13. PubMed ID: 15583821
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Y inhibits depolarization-stimulated catecholamine synthesis in rat pheochromocytoma cells.
McCullough LA; Westfall TC
Eur J Pharmacol; 1995 Dec; 287(3):271-7. PubMed ID: 8991801
[TBL] [Abstract][Full Text] [Related]
5. BODIPY-conjugated neuropeptide Y ligands: new fluorescent tools to tag Y1, Y2, Y4 and Y5 receptor subtypes.
Dumont Y; Gaudreau P; Mazzuferi M; Langlois D; Chabot JG; Fournier A; Simonato M; Quirion R
Br J Pharmacol; 2005 Dec; 146(8):1069-81. PubMed ID: 16231000
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of Y receptors and signaling pathways in intestinal circular and longitudinal smooth muscle.
Misra S; Mahavadi S; Grider JR; Murthy KS
Regul Pept; 2005 Feb; 125(1-3):163-72. PubMed ID: 15582728
[TBL] [Abstract][Full Text] [Related]
7. PC12 rat pheochromocytoma cells synthesize dynorphin. Its secretion is modulated by nicotine and nerve growth factor.
Margioris AN; Markogiannakis E; Makrigiannakis A; Gravanis A
Endocrinology; 1992 Aug; 131(2):703-9. PubMed ID: 1353443
[TBL] [Abstract][Full Text] [Related]
8. [Leu31-Pro34] neuropeptide Y identifies a subtype of 125I-labeled peptide YY binding sites in the rat brain.
Gehlert DR; Gackenheimer SL; Schober DA
Neurochem Int; 1992 Jul; 21(1):45-67. PubMed ID: 1303142
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide Y modulates effects of bradykinin and prostaglandin E2 on trigeminal nociceptors via activation of the Y1 and Y2 receptors.
Gibbs JL; Diogenes A; Hargreaves KM
Br J Pharmacol; 2007 Jan; 150(1):72-9. PubMed ID: 17143304
[TBL] [Abstract][Full Text] [Related]
10. Neuropeptide Y induced attenuation of catecholamine synthesis in the rat mesenteric arterial bed.
Westfall TC; Naes L; Gardner A; Yang CL
J Cardiovasc Pharmacol; 2006 Jun; 47(6):723-8. PubMed ID: 16810071
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP.
Dumont Y; Thakur M; Beck-Sickinger A; Fournier A; Quirion R
Neuropeptides; 2004 Aug; 38(4):163-74. PubMed ID: 15337369
[TBL] [Abstract][Full Text] [Related]
12. Actions of neuropeptide Y on the rat adrenal cortex.
Renshaw D; Thomson LM; Carroll M; Kapas S; Hinson JP
Endocrinology; 2000 Jan; 141(1):169-73. PubMed ID: 10614636
[TBL] [Abstract][Full Text] [Related]
13. Specific 125I neuropeptide Y binding to intact cultured bovine adrenal medulla capillary endothelial cells.
Sanabria P; Silva WI
Microcirculation; 1994 Dec; 1(4):267-73. PubMed ID: 8790595
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptide Y1 subtype pharmacology of a recombinantly expressed neuropeptide receptor.
Krause J; Eva C; Seeburg PH; Sprengel R
Mol Pharmacol; 1992 May; 41(5):817-21. PubMed ID: 1316999
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of stimulated cyclic AMP production by multiple neuropeptide Y receptors in the rat brainstem.
Ny L; Grundemar L
Neurosci Lett; 1997 Jan; 221(2-3):113-6. PubMed ID: 9121677
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide Y suppresses the neurogenic inflammatory response in the rabbit eye; mode of action.
Grundemar L; Wahlestedt C; Wang ZY
Regul Pept; 1993 Jan; 43(1-2):57-64. PubMed ID: 8381238
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide Y and the retinal pigment epithelium: receptor subtypes, signaling, and bioelectrical responses.
Ammar DA; Hughes BA; Thompson DA
Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1870-8. PubMed ID: 9727410
[TBL] [Abstract][Full Text] [Related]
18. Autoreceptor-induced inhibition of neuropeptide Y release from PC-12 cells is mediated by Y2 receptors.
Chen X; DiMaggio DA; Han SP; Westfall TC
Am J Physiol; 1997 Oct; 273(4):H1737-44. PubMed ID: 9362238
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of nicotinic acetylcholine receptor channels in bovine adrenal chromaffin cells by Y3-type neuropeptide Y receptors via the adenylate cyclase/protein kinase A system.
Nörenberg W; Bek M; Limberger N; Takeda K; Illes P
Naunyn Schmiedebergs Arch Pharmacol; 1995 Apr; 351(4):337-47. PubMed ID: 7543184
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y induces gonadotropin-releasing hormone gene expression directly and through conditioned medium from mHypoE-38 NPY neurons.
Dhillon SS; Gingerich S; Belsham DD
Regul Pept; 2009 Aug; 156(1-3):96-103. PubMed ID: 19371763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
